Rosiglitazone → myocardial infarction — Null result

Drug: rosiglitazone · AE: myocardial infarction · vs pioglitazone

Caliper validation of the submitted claim (drug=rosiglitazone, AE=myocardial infarction, comparator=pioglitazone). BELOW_DEDUP_THRESHOLD — only 0 unique cases after dedup; insufficient signal density

Disproportionality

• PRR: 49.7853033791773 (95% CI 7.01–353.44)
• Yates χ²: 0
• Cases (case-drug + AE): n = 0
• Verdict: BELOW_DEDUP_THRESHOLD — only 0 unique cases after dedup; insufficient signal density

Top reactions in cohort

Source: openFDA FAERS, Caliper Engine v0. Pre-registration sha1 locked at submission time; ledger entry signed with platform Ed25519 key.